China Mammography Market Industry Trends and Forecast to 2034: Segmented by (Product, Setting, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Overview
Market Dashboard
China · 2024–2034 · placeholder estimates
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the
full report.
Estimate 2024$208.0 MnPlaceholder estimate
Estimate 2025$228.0 Mn8.9% of the global market
Projected 2034$520.3 Mn 128.2%Adds $292.3 Mn over 9 forecast years
CAGR 2025–20349.6%Faster than 44% of 180 Medical Devices markets here
Key players5
China is 8.88% of the global market.
In APAC, the largest is China (this report) at $228.0 Mn.
1,013 in ChinaSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in China. Retrieved 20 Nov 2026.
Formats
PDF, PPTX, XLSX
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
The China Mammography Market Analysis Executive Summary
Mammography systems take low-dose X-ray images of the breast to find cancer early.
Key segments of the mammography market include product (2D Digital Mammography, 3D Tomosynthesis and Contrast-Enhanced Mammography) and setting (Hospitals, Breast Care Centers and Diagnostic Centers).
China Mammography market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.
China Mammography Market Dynamics
Market Growth Drivers
More imaging for cancer and heart disease, older populations and sharper, faster scanners are driving the mammography market. Clinicians also use imaging earlier in care.
Opportunity
AI-assisted reading, compact systems for clinics and the replacement of old scanners give the mammography market room to grow.
Market Restraints
High equipment prices, a shortage of trained staff and long replacement cycles in public hospitals hold back the mammography market.
Competitive Landscape for Mammography Market in China
The mammography market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Healthcare Policies and Regulatory Landscape for Mammography Market in China
Mammography in China: rules, payment and research
Medical devices are regulated by the National Medical Products Administration (NMPA) and its provincial offices: class I devices are filed, and class II and III devices are registered.[1] Basic medical insurance covers most people; the National Healthcare Security Administration (NHSA) runs it and sets the National Reimbursement Drug List.[2] ClinicalTrials.gov lists 1,013 studies on Mammography that are recruiting, active or about to start in China.[3]
[3]ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in China. Retrieved 20 Nov 2026.
Policy changes and Reimbursement scenario
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how mammography products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in China.
Sources:PubMed (US National Library of Medicine),
ClinicalTrials.gov,
World Bank.
Fetched 20 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
Public data, with sources
Mammography in context
China compared
Health spending per person: 763 US$ per person (2023). World: 1,317 US$ per person (2023). 6th highest of the 17 countries we cover in APAC.[1]
Doctors: 3.11 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 3rd highest of the 17 countries we cover in APAC.[2]
People aged 65 and over: 14.9% of people (2025). World: 10.4% of people (2025). 7th highest of the 18 countries we cover in APAC.[3]
[1]World Bank Open Data, Health spending per person (US$ per person). Retrieved 19 Nov 2026.
Placeholder estimate: about $228.0 Mn in 2025, rising to about $520.3 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Mammography market in China growing?
Placeholder estimate: about 9.6% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Mammography market report cover?
The report splits the market by product (2D Digital Mammography, 3D Tomosynthesis, Contrast-Enhanced Mammography) and setting (Hospitals, Breast Care Centers, Diagnostic Centers).
Who are the key players in the Mammography market?
Key players include Hologic, Inc., GE Healthcare, Siemens Healthineers, FUJIFILM Holdings Corporation and Planmed.
What is driving the Mammography market?
More imaging for cancer and heart disease, older populations and sharper, faster scanners are driving the mammography market. Clinicians also use imaging earlier in care.
Who regulates Mammography in China?
Medical devices are regulated by the National Medical Products Administration (NMPA) and its provincial offices: class I devices are filed, and class II and III devices are registered. Source: National Medical Products Administration. Checked 14 Nov 2026.
How is healthcare paid for in China?
Basic medical insurance covers most people; the National Healthcare Security Administration (NHSA) runs it and sets the National Reimbursement Drug List. Source: National Healthcare Security Administration. Checked 14 Nov 2026.
How many clinical trials on Mammography are running in China?
1,013 studies are recruiting, active or about to start in China, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in China. Retrieved 20 Nov 2026.
How much research is published on Mammography?
PubMed lists 7,524 papers on Mammography added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 20 Nov 2026.